Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regan L Harmon

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancers|March 28, 2025
Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck CancerKourtney L Kostecki, Regan L Harmon, Mari Iida, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Head and Neck CancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
International Forum of Allergy & Rhinology|January 15, 2025
Long-Term Implications of Short-Term Symptom and Radiographic Severity Outcomes After ESS in CRS PatientsAditi Agarwal, Zhidi Luo, Siyuan Dong, et al.
Frontiers in Oncology|May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
International Forum of Allergy & Rhinology|December 19, 2025
Effect and Threshold of Endoscopic Findings for CRS Control Status and Long-Term Outcome PredictionSteven Chun-Kang Liao, Aditi Agarwal, Junqin Bai, et al.
International Forum of Allergy & Rhinology|September 26, 2025
Factor Analysis-Based Quantitative Endotyping Improves Associations With CRS Cross-Sectional and Longitudinal OutcomesBrooke N Gleason, Zhidi Luo, Aditi Agarwal, et al.
Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancers|March 28, 2025
Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck CancerKourtney L Kostecki, Regan L Harmon, Mari Iida, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Head and Neck CancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
International Forum of Allergy & Rhinology|January 15, 2025
Long-Term Implications of Short-Term Symptom and Radiographic Severity Outcomes After ESS in CRS PatientsAditi Agarwal, Zhidi Luo, Siyuan Dong, et al.
Frontiers in Oncology|May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
International Forum of Allergy & Rhinology|December 19, 2025
Effect and Threshold of Endoscopic Findings for CRS Control Status and Long-Term Outcome PredictionSteven Chun-Kang Liao, Aditi Agarwal, Junqin Bai, et al.
International Forum of Allergy & Rhinology|September 26, 2025
Factor Analysis-Based Quantitative Endotyping Improves Associations With CRS Cross-Sectional and Longitudinal OutcomesBrooke N Gleason, Zhidi Luo, Aditi Agarwal, et al.
Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.
Pageof 1